Quest PharmaTech Ownership

Pink Sheets . USA . 
Stock . Quest PharmaTech
QPTFF Stock  USD 0.01  0.00  0.00%   
Quest PharmaTech owns a total of 169.13 Million outstanding shares. Quest PharmaTech holds 16.8 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Quest PharmaTech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Quest PharmaTech, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quest PharmaTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Quest Pink Sheet Ownership Analysis

About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.19. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Quest PharmaTech recorded a loss per share of 0.39. The entity had not issued any dividends in recent years. Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications skin penetrating active molecules for cosmetic and pharmaceutical use and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest Pharmatech is traded on OTC Exchange in the United States.The quote for Quest PharmaTech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Quest PharmaTech contact Ragupathy Madiyalakan at 780 448 1400 or learn more at https://www.questpharmatech.com.

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Quest Pink Sheet

Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY